12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Company News  |  Deals

GenVec, Novartis deal

GenVec received an undisclosed milestone payment from Novartis under a January deal that granted the pharma exclusive, worldwide rights to GenVec's hearing loss and balance...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >